Olympus invests heavily in Hamburg: medical technology manufacturer is building a new building in the City Süd and is expanding the development and production location in Jenfel
15.02.2017 • Hamburg – Olympus is on a growth course and is expanding its location in Hamburg massively. In the district of Hammerbrook the company is building a new building for marketing and sales of its products in EMEA (Europe, Middle East and Africa) and Olympus Deutschland GmbH. In Jenfeld, it is expanding its European development and production center for medical technology. It is one of the largest building investments of a company in Hamburg in recent years. The new building in the City South is expected to be completed by 2020. Responsible for the design is the Hamburg architectural office of Gerkan, Marg and Partner (gmp).
More space, an inspiring work environment, modern architecture: the new company center will offer employees of today and tomorrow a highly modern work environment. From open space to retreats to cafes and sports facilities, the offices meet the needs of the “new work”.
With the new building, Olympus reacts to its targeted growth. “We are planning a strategic global growth of six percent by 2021, according to the trend in recent years. The new building takes this development into account and will provide our employees with a modern and inspiring work environment”. “At the same time, with the buildings in Hammerbrook and Jenfeld, we are clearly the biggest Japanese employer in the Hansestadt.”
Another good news for Hamburg: Olympus is planning and planning up to five per cent more jobs annually in the fields of marketing, sales and service, research and development as well as production – especially in medical technology. The additional jobs were taken into account in the expansion plans. “We are pleased that Olympus is investing further in the location as a major employer in Hamburg,” says Prof. Jörn Walter, Director of the City of Hamburg. “The new building is not only an architecturally successful addition to the Heidenkampweg, but also an important milestone in the development of the district of Hammerbrook – in the long term, a mixed area consisting of commercial and complementary residential use is to be created here.”
New company center in Wendenstrasse
The new company center is built on the site between Heidenkampsweg, Wendenstraße and Sachsenstraße. It covers a total area of 55,000 square meters. The new headquarters will demolish all currently used buildings, since their modernization would involve too much effort. The employees are temporarily moving to the Poseidonhaus on the Amsinckstrasse – also in Hammerbrook, where Olympus already signed a contract for renting 23,800 square meters of space last year.
Part of the new building in the City Süd will also be a highly modern training center. The demand for advanced training, in particular, is increasing as a result of Olympus’ advance in surgical devices. In the future, employees from all over EMEA will be trained at the new headquarters.
The Hamburg architectural office of Gerkan, Marg and Partner (gmp) is responsible for the new construction of the company center. The international office is renowned for its architectural achievements in all architectural and urban development disciplines. As part of the appraisal procedure, gmp was able to compete with three other offices. They provided the most convincing architectural design. The proposals were evaluated by a commission of municipal representatives, the Olympus board as well as the project manager of Olympus.
European development and production center in Kuehnstrasse
The European development and production center in Kuehnstrasse will be expanded by 20,000 square meters by the summer of 2018. “Here tomorrow’s medical technology will be designed and built for the world market,” says Kaufmann. “At the Hamburg location, we are strengthening our development and manufacturing competences for rigid endoscopy, bipolar high-frequency surgery, system integration and instrument processing, thereby contributing to our global growth in medical technology.”